Nothing Special   »   [go: up one dir, main page]

IL154227A0 - Chemokine receptor binding heterocyclic compounds - Google Patents

Chemokine receptor binding heterocyclic compounds

Info

Publication number
IL154227A0
IL154227A0 IL15422701A IL15422701A IL154227A0 IL 154227 A0 IL154227 A0 IL 154227A0 IL 15422701 A IL15422701 A IL 15422701A IL 15422701 A IL15422701 A IL 15422701A IL 154227 A0 IL154227 A0 IL 154227A0
Authority
IL
Israel
Prior art keywords
receptor binding
heterocyclic compounds
chemokine receptor
binding heterocyclic
ccr5
Prior art date
Application number
IL15422701A
Other languages
English (en)
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of IL154227A0 publication Critical patent/IL154227A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
IL15422701A 2000-09-15 2001-09-17 Chemokine receptor binding heterocyclic compounds IL154227A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23289100P 2000-09-15 2000-09-15
US23451000P 2000-09-22 2000-09-22
PCT/CA2001/001326 WO2002022600A2 (en) 2000-09-15 2001-09-17 Chemokine receptor binding heterocyclic compounds

Publications (1)

Publication Number Publication Date
IL154227A0 true IL154227A0 (en) 2003-07-31

Family

ID=26926422

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15422701A IL154227A0 (en) 2000-09-15 2001-09-17 Chemokine receptor binding heterocyclic compounds

Country Status (22)

Country Link
US (3) US6864265B2 (tr)
EP (1) EP1317445B1 (tr)
JP (1) JP2004508422A (tr)
KR (1) KR20030029998A (tr)
CN (1) CN1457339A (tr)
AT (1) ATE425157T1 (tr)
AU (2) AU9156901A (tr)
BR (1) BR0113930A (tr)
CA (1) CA2419224A1 (tr)
DE (1) DE60137944D1 (tr)
ES (1) ES2325909T3 (tr)
HK (1) HK1052011A1 (tr)
HU (1) HUP0301093A2 (tr)
IL (1) IL154227A0 (tr)
MX (1) MXPA03002326A (tr)
NO (1) NO20031179L (tr)
NZ (1) NZ524420A (tr)
PL (1) PL360932A1 (tr)
RU (1) RU2289581C2 (tr)
SG (1) SG126007A1 (tr)
TR (1) TR200300322T2 (tr)
WO (1) WO2002022600A2 (tr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60143457D1 (de) 2000-09-15 2010-12-23 Anormed Inc Chemokin Rezeptor bindende heterozyklische Verbindungen
DE60137435D1 (de) * 2000-09-15 2009-03-05 Anormed Inc Chemokin rezeptor bindenden heterozyklische verbindungen
US6864265B2 (en) * 2000-09-15 2005-03-08 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
US7169750B2 (en) 2001-07-31 2007-01-30 Anormed, Inc. Methods to mobilize progenitor/stem cells
PL364673A1 (en) 2001-07-31 2004-12-13 Anormed Inc. Methods to mobilize progenitor/stem cells
US7354932B2 (en) 2001-12-21 2008-04-08 Anormed, Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
PL369856A1 (en) * 2001-12-21 2005-05-02 Anormed Inc. Chemokine receptor binding heterocyclic compounds with enhanced efficacy
AU2003261974A1 (en) * 2002-09-11 2004-04-30 Kureha Chemical Industry Company, Limited Amine compounds and use thereof
US7504422B2 (en) 2003-04-02 2009-03-17 Taigen Biotechnology Co. Ltd. Polyamine compounds
CA2521416A1 (en) 2003-04-02 2004-10-21 Taigen Biotechnology Polyamine compounds for treating chemokine receptor mediated diseases
EP1613613B1 (en) 2003-04-11 2021-06-02 Genzyme Corporation Cxcr4 chemokine receptor binding compounds
WO2004092169A1 (ja) * 2003-04-18 2004-10-28 Ono Pharmaceutical Co., Ltd. スピロピペリジン化合物およびその医薬用途
US7501518B2 (en) 2003-04-22 2009-03-10 Genzyme Corporation Methods of making 2,6-diaryl piperidine derivatives
KR20050115455A (ko) 2003-04-22 2005-12-07 아노르메드 인코포레이티드 효능이 증강된 케모킨 수용체 결합 헤테로사이클 화합물
JP2007501189A (ja) * 2003-08-01 2007-01-25 ジェネラブス テクノロジーズ，インコーポレイテッド フラビウイルス科に対する二環式イミダゾール誘導体
WO2005059107A2 (en) 2003-12-11 2005-06-30 Anormed Inc. Chemokine receptor binding compounds
US7498346B2 (en) 2003-12-11 2009-03-03 Genzyme Corporation Chemokine receptor binding compounds
KR101149124B1 (ko) * 2004-03-10 2012-05-25 가부시끼가이샤 구레하 아민계 염기성 화합물과 그의 용도
BRPI0508703B8 (pt) * 2004-03-15 2021-05-25 Anormed Inc processo para a síntese de um antagonista de cxcr4
US7179827B2 (en) * 2004-03-31 2007-02-20 Lexicon Genetics Incorporated Thiazoles and methods of their use
BRPI0514343A (pt) * 2004-08-13 2008-06-10 Anormed Inc combinações de quimiocinas para mobilizar células progenitoras/tronco
PE20060646A1 (es) * 2004-08-16 2006-08-04 Smithkline Beecham Corp Derivados de bencimidazol como moduladores de la actividad de quimioquinas
RU2392923C2 (ru) * 2004-08-19 2010-06-27 Колгейт-Палмолив Компани Увеличенная доставка масла из структурированных композиций поверхностно-активного вещества
US7951816B2 (en) 2004-08-27 2011-05-31 Ono Pharmaceutical Co., Ltd. Compound containing basic group and use thereof
EP1799671A4 (en) * 2004-09-02 2009-06-10 Smithkline Beecham Corp CHEMICAL COMPOUNDS
US20080171740A1 (en) * 2004-09-24 2008-07-17 Smithkline Beecham Corporation Chemical Compounds
TW200619206A (en) * 2004-09-29 2006-06-16 Anormed Inc Chemokine-binding heterocyclic compound salts, and methods of use thereof
EP1844042A1 (en) * 2005-01-14 2007-10-17 Genelabs Technologies, Inc. Indole derivatives for treating viral infections
US7501526B2 (en) 2005-01-20 2009-03-10 Taigen Biotechnology Synthesis of polyamine compounds
US7790747B2 (en) 2005-06-15 2010-09-07 Genzyme Corporation Chemokine receptor binding compounds
WO2007008539A2 (en) * 2005-07-11 2007-01-18 Smithkline Beecham Corporation Pyranopyridine compounds
CA2619828A1 (en) 2005-08-19 2007-02-22 Genzyme Corporation Methods to enhance chemotherapy
US8168783B2 (en) 2005-11-18 2012-05-01 Ono Pharmaceutical Co., Ltd. Chemokine receptor antagonists and use thereof
US7671069B2 (en) 2006-03-30 2010-03-02 Chemocentryx, Inc. Tricyclic, heteroaromatic compounds modulating CXCR4 and/ or CXCR7
US7807704B2 (en) * 2006-03-30 2010-10-05 Chemocentryx, Inc. Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2
EP2042503B1 (en) 2006-05-16 2013-01-30 Ono Pharmaceutical Co., Ltd. Compound having acidic group which may be protected, and use thereof
CN101495115A (zh) * 2006-08-02 2009-07-29 健赞股份有限公司 组合治疗
AU2007281677A1 (en) * 2006-08-07 2008-02-14 Genzyme Corporation Combination therapy
WO2009036341A2 (en) * 2007-09-14 2009-03-19 The Regents Of The University Of Michigan Compositions and methods relating to hiv protease inhibition
RU2507202C2 (ru) * 2008-07-02 2014-02-20 Ф.Хоффманн-Ля Рош Аг Новые фенилпиразиноны в качестве ингибиторов киназы
JP2012502048A (ja) * 2008-09-08 2012-01-26 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法
US8969381B2 (en) 2010-12-03 2015-03-03 Emory University Chemokine CXCR4 receptor modulators and used related thereto
CN102603683B (zh) * 2012-02-10 2014-04-09 山东大学 一种呋喃类化合物及其制备方法与应用
CN104478795A (zh) * 2014-11-24 2015-04-01 苏州乔纳森新材料科技有限公司 一种2-氯烟醛的制备方法
CA3026154A1 (en) 2015-06-03 2016-12-08 The University Of Queensland Mobilizing agents and uses therefor
CN104945313A (zh) * 2015-06-19 2015-09-30 洪帅金 一种2-甲基-3-溴吡啶的制备方法
NZ741093A (en) * 2015-10-06 2022-12-23 Proteostasis Therapeutics Inc Compounds, compositions, and methods for modulating cftr
CN105198802A (zh) * 2015-11-03 2015-12-30 江苏梦得电镀化学品有限公司 一种2-甲基-3-溴吡啶的制备方法
CA3008279A1 (en) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Methods for treating cancer
ES2907489T3 (es) 2015-12-14 2022-04-25 X4 Pharmaceuticals Inc Métodos para el tratamiento del cáncer
US10610527B2 (en) 2015-12-22 2020-04-07 X4 Pharmaceuticals, Inc. Methods for treating immunodeficiency disease
CN109153722A (zh) 2016-04-08 2019-01-04 X4 制药有限公司 用于治疗癌症的方法
CN109640988A (zh) 2016-06-21 2019-04-16 X4 制药有限公司 Cxcr4抑制剂及其用途
US10759796B2 (en) 2016-06-21 2020-09-01 X4 Pharmaceuticals, Inc. CXCR4 inhibitors and uses thereof
CA3027500A1 (en) 2016-06-21 2017-12-28 X4 Pharmaceuticals, Inc. Cxcr4 inhibitors and uses thereof
WO2018073248A1 (en) 2016-10-17 2018-04-26 Icm (Institut Du Cerveau Et De La Moelle Épinière) Prognosis of demyelinating diseases patients and treatment thereof
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
GB201910608D0 (en) * 2019-07-24 2019-09-04 Enterprise Therapeutics Ltd Compounds
CN112110853A (zh) * 2020-09-23 2020-12-22 海南梵圣生物科技有限公司 一种合成3-羟基-2-吡啶甲酸及其衍生物的方法
CN116375650A (zh) * 2022-12-30 2023-07-04 浙江美诺华药物化学有限公司 一种替戈拉生中间体的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001826A (en) * 1989-12-21 1999-12-14 Anormed, Inc. Chemical compounds
US5021409A (en) 1989-12-21 1991-06-04 Johnson Matthey Plc Antiviral cyclic polyamines
GB9126677D0 (en) 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
GB9400411D0 (en) 1994-01-11 1994-03-09 Johnson Matthey Plc Improvements in chemical compounds
GB9511357D0 (en) * 1995-06-06 1995-08-02 Johnson Matthey Plc Improved antiviral compounds
CN1264373A (zh) 1997-07-16 2000-08-23 西巴特殊化学品控股有限公司 多缩水甘油基螺环化合物及其在环氧树脂中的应用
CA2319781A1 (en) * 1998-02-02 1999-08-05 Liping Wang Cyclic amine modulators of chemokine receptor activity
JPH11269146A (ja) * 1998-03-24 1999-10-05 Mitsui Chem Inc 分化誘導剤
EP1146790A4 (en) * 1999-01-25 2004-03-17 Smithkline Beecham Corp COMPOUNDS AND METHODS
AU3386500A (en) * 1999-03-02 2000-09-21 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
US6750348B1 (en) * 1999-03-24 2004-06-15 Anormed, Inc. Chemokine receptor binding heterocyclic compounds
TR200102799T2 (tr) * 1999-03-24 2002-07-22 Anormed Inc. Kemokin alıcı bağlayıcı heterosiklik bileşikler
DE60137435D1 (de) * 2000-09-15 2009-03-05 Anormed Inc Chemokin rezeptor bindenden heterozyklische verbindungen
US6864265B2 (en) * 2000-09-15 2005-03-08 Anormed, Inc. Chemokine receptor binding heterocyclic compounds

Also Published As

Publication number Publication date
ATE425157T1 (de) 2009-03-15
US20040220207A1 (en) 2004-11-04
NZ524420A (en) 2005-04-29
TR200300322T2 (tr) 2003-09-22
CN1457339A (zh) 2003-11-19
WO2002022600A3 (en) 2002-05-10
HUP0301093A2 (hu) 2003-09-29
US20030018046A1 (en) 2003-01-23
EP1317445B1 (en) 2009-03-11
US20060128750A1 (en) 2006-06-15
US6864265B2 (en) 2005-03-08
US7396840B2 (en) 2008-07-08
SG126007A1 (en) 2006-10-30
PL360932A1 (en) 2004-09-20
AU9156901A (en) 2002-03-26
AU2001291569B2 (en) 2007-07-26
WO2002022600A2 (en) 2002-03-21
KR20030029998A (ko) 2003-04-16
US7084155B2 (en) 2006-08-01
JP2004508422A (ja) 2004-03-18
NO20031179D0 (no) 2003-03-14
CA2419224A1 (en) 2002-03-21
BR0113930A (pt) 2003-06-24
EP1317445A2 (en) 2003-06-11
MXPA03002326A (es) 2003-06-06
HK1052011A1 (zh) 2003-08-29
ES2325909T3 (es) 2009-09-24
DE60137944D1 (de) 2009-04-23
RU2289581C2 (ru) 2006-12-20
NO20031179L (no) 2003-03-14

Similar Documents

Publication Publication Date Title
AU9156901A (en) Chemokine receptor binding heterocyclic compounds
UA87473C2 (en) Muscarinic acetycholine receptor antagonists
WO2002034745A8 (en) Chemokine receptor binding heterocyclic compounds
PL356034A1 (en) Cyclic amine compounds as ccr5 antagonists
TR200102029T2 (tr) 1-Heterosiklil ikameli diarilaminler.
HUP0200761A2 (en) Chemokine receptor binding heterocyclic compounds, pharmaceutical compositions containing them and their use
GB0130347D0 (en) Compounds
HK1039330A1 (en) Piperidine derivatives useful as ccr5 antagonists.
UY27927A1 (es) Antagonistas del receptor muscarínico m3 de acetilcolina
EP1117692A4 (en) ANTIBODIES AGAINST TIE2 ANTAGONISTS
DE69837606D1 (de) Cystein-reiche rezeptoren-train
IL179733A0 (en) Novel piperidine-8-azabicyclo(3.2.1)octan derivatives as modulators of chemokine receptor ccr5
ECSP066486A (es) Antagonistas de receptores de acetilcolina muscarínicos ii
WO2001096565A3 (en) Binding agents: chimeric ligand/receptor proteins
MXPA06000662A (es) Antagonistas del receptor muscarinico de acetilcolina.
TW200519108A (en) Muscarinic acetylcholine receptor antagonists
MXPA06000664A (es) Antagonistas del receptor muscarinico de acetilcolina.
AU2003255501A1 (en) Cxcr4 receptor antagonists
SG144934A1 (en) C5a receptor antagonists
BG105761A (en) Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
TW200531686A (en) Pharmaceutical compositions
AU2003267088A8 (en) Chemokine receptor antagonists as therapeutic agents
EP1248607A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS
HK1046414A1 (zh) 趨化因子受體ccr3拮抗劑
EP1246619A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS